Cleared Traditional

K230675 - VITEK REVEAL GN AST Assay and VITEK REVEAL AST System (FDA 510(k) Clearance)

Jun 2024
Decision
468d
Days
Class 2
Risk

K230675 is an FDA 510(k) clearance for the VITEK REVEAL GN AST Assay and VITEK REVEAL AST System. This device is classified as a Automated Antimicrobial Susceptibility Test System For Positive Blood Culture Samples (Class II - Special Controls, product code SAN).

Submitted by Specific Diagnostics, LLC (San Jose, US). The FDA issued a Cleared decision on June 20, 2024, 468 days after receiving the submission on March 10, 2023.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1650. Automated System That Performs Antimicrobial Susceptibility Testing Using Positive Blood Culture Samples.

Submission Details

510(k) Number K230675 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 10, 2023
Decision Date June 20, 2024
Days to Decision 468 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code SAN - Automated Antimicrobial Susceptibility Test System For Positive Blood Culture Samples
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1650
Definition Automated System That Performs Antimicrobial Susceptibility Testing Using Positive Blood Culture Samples